В литературе представлены факторы риска, причины, механизмы развития ранней анемии у недоношенных детей с НМТ. Была также представлена информация о профилактике и лечении ранней анемии, включая обоснование эффективности и использования эритропо-этина.
Stranss R.G. Anemia of prematurity: Pathophysiology and treatment. Blood Rev. 2010.-vol.24, №6.-p.221-225.
Сахарова Е.С. Анемия недоношенных детей. Патогенез, диагностика, лечение и профилактика. Медицинский совет. 2015, №6,-с.10-17.
Stockman J.A. Anemia of prematurity: current concepts in the issue of when to transfuse. Pediatr Clin.North Am.-1986.-vol.33. №1, p.111-128.
Widness J.A. Pathophysiology. Diagnosis and Prevention on Neonatal Anemia.// Neo Reviews. 2000.-vol.1.№4.p.20-25.
Демихов В.Г., Дмитриев А.В., Шокер О.А. Ранняя анемия недоношенных: оптимизация стратегии терапии. Росс. журнал детской гемат. и онкол. 2015, т.1, с.81-87.
Cassady G. Anemia of Prematurity. Chief Editor T.Rosenkrants, 2016.p.114.
Детская гематология. Клинические рекомендации /под.ред. А.Г.Румянцева, А.А.Масчана, Е.В.Жуковский - М.:Гэотар-Медия, 2015.с.182-192.
Жетишев Р.А., Шабалов Н.П., Иванов Д.Д. Анемии новорожденных. Диагностика, профилактика, лечение: клинические рекомендации.-2015.-19с.
New H.V., Berryman J., Bolton-Maggs H.B. et al. British Journal of Haematology.-2016.vol.175. №5.p.784-828.
Von Lindern J.S., Lopriore E. Management and prevention of neonatal anemia: current evidence and guidelines. Expert Rev.Hematol.-2014.vol.7., №2, p.195-202.
Бурлев В.А., Павлович С.В. Проблемы репродукции, 2002, №4.-с.29-33.
Всемирная организация здравоохранения. База данных «Здоровье для всех». Hemoglobin concentrations for the diagnosis of anemia and assessment of severity. Geneva, 2011. [Электронный ресурс]. Режим доступа: http://www.who.int/vmnis/indicators/haemoqlobin.ru.
Савальева Г.М., Сухих Г.Т., Серов В.Н. Акушерство. Национальное руководство. 2-е издание.-М.:Гэотар-Медиа, 2018.-с.640.
Nair M., Churchill D., Robinson S., Association between maternal hemoglobin and stillbirth: a cohort study among a multi-ethnic population in England. Br.J.Haematol. 2017.-vol.179.№5.p.829-837.
Тютюнник В.Л., Кан Н.Е., Павлович С.В., Михайлова О.И. и др. Железодефицитные состояние у беременных, родильниц и гинекологических больных: учеб.пособие.-М.:Гэотар-Медиа.2019-с.58.
Alwan N.A., Cade J.E., Mc.Ardle H.J. et al. Maternal iron status in early pregnancy and birth outcomes: insights from the Baby's Vascular health and Iron in Pregnancy study. British Journal of Nutrition. 2019. p.113.
Bakacak M., Fazil A., Onder E. et al. The effect of maternal hemoglobin concentration on fetal birth weight according to trimesters. J.Matern Fetal Neonatal Med.-2015.-vol.28.№17.-p.2101-2110.
Drukker L., Hants Y., Farkash R., Ruchlemer R. et al. Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean Section and adverse maternal and neonatal outcomes Transfusion.-2019.-vol.55.№12.p.2799-2806.
Lelic M., Boqdanovic G., Ramic S., Brkicevic E. Influence of maternal anemia during pregnancy on placenta and new borns. Med.Arch.2014, vol.68.,№3.p.184-187.
Orlandini C., Torricelli M., Spirito N. et al. Maternal anemia effects during pregnancy on males and females fetuses: are there any differences? The Journal of Maternal–Fetal and Neonatal Medicine 2017. Vol.30, №14.p.1704-1708.
Rahman M.M., Abe S.K., Rahman M.S. et al. Maternal anemia and risk of adverse birth and health out-comes in low and middle-income countries: systematic review and meta-analysis. Am.J.Clin Nutr. 2016, vol.103.№2.495-504.
Vural T., Toz E., Ozcan A., Biler A. et al. Can anemia predict perinatal outcomes in different stages of pregnancy? J.Med.Sci:-2016.-vol.32.№6. p.1354-1359.
Yildiz Y., Ozgu E., Unlu S.B. The relation ship between third trimestr maternal hemoglobin and birth weight/length; results from the tertiary center in Turkey. J.Matern Fetal Neonatal Med.2014.vol.27. №7.p.729-732.
Sekhavat L., Davar R., Hosseinidezoki. Relationship between maternal hemoglobin concentration and neonatal birth weight. Hematology, 2014, vol.16, №6.p.373-376.
Willner E., de Sa S.A., Durases T.A. et al. Anemia in pregnancy: impact on weight and in the development of anemic in newborn. Nutr Hosp. 2015, vol.32, №5,-p.2071-2079.
Haider B.A., Olofin J., Wang M. et al. Nutrition Impact Model Study Group (anemia). Anemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ., 2013. Vol.346.p.34-43.
Chapman J., Marfurt S., Reid J. Effectiveness of Delayed Cord Clamping in Reducing Postdelivery Complications in Preterm Infants: A Systematic Review J Perinatal Neonatal Nurs. 2016. Vol.30. №4, p.372-379
Carroll P.D., Umbilical cord blood-an untapped resource: strategies to decrease early red blood cell transfusions and improve neonatal outcomes. Clin Perinatal. 2015.vol.42.№3.p.541-556.
American Heart Association. Web-based integrated guidelines for cardiopulmonary resuscitation and emergency cardiovascular care e part 13: neonatal resuscitation. [Электронный ресурс]. – ECC guidelines, heart. org.2015.
Katheria A.C., Truong G., Cousing L. et al. Umbilical Cord Milking Versus Delayed Cord Clamping in Preterm Infants. Pediatrics. 2015. Vol.136.№1.p.61-69.
Rabe H., Diaz-Rossello J.L., Duley L., Dowswell T. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev. 2012. vol.8.p.248.
Aher S.M., Ohlsson A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst.Rev. 2012.-10.
Cai Y.J., Song Y.Y., Huang Z.J. Effects of recombinant human erythropoietin on neurointelligence development in very low birth weight infants. Zhougguo Dang Dai Er. 2013. vol.15. №12.p.1064-1067.
Fanchere J.C., Koller B.M., Tschopp A. et al. Safety of early high dose recombinant erythropoietin for neuroprotection in very preterm infants. J.Pediatr.2015. vol.167.№1, p.52-57.
Franklin H.B. Erythropoietin Hematology Division. Cold Spring Harb Perspect Med. 2013. Vol.3, №3.p.116-119.
Juul S. Erythropoietin in anemia of prematuriry. J.Matern Fetal Neonatal Med. 2012. vol. 25.№5.p.80-84.
Leuchter R.H., Gui L., Poncet A., Association between early administration of high-dose erythropoietin in preterm infants: EPO in very Preterm Infants and brain MRJ abnormality at term-equivalent age. JAMA.2014.vol.312. №8.p.817-824.
Ohlsson Aher S.M. Early erythropoietin for preventing red blood cell transfusion in preterm and /or low birth weight infants. Cochrane Dababase Syst Rev. 2012. vol.12.№9.p.95.
Crowley M., Kirpalani H. A rational approach to red blood cell transfusion in the neonatal JCU. Curr Opin Pediatr.2016. vol.22.№2.p.151-157.
Chen H.L., Tseng H.J., Lu C.C., Yang S.N. Effect of blood transfusions on the outcomes of very low body weight preterm infants under two different transfusion criteria Pediatr.Neonatal. 2009. vol.50.№3.p.110-116.
Becquit O., Guyot D., Kuo P.et al. Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants. BMC Pediatr.2013.p.176.
Onlsson A., Aher S.M., Early erythropoiesis –stimulating agents in preterm or low birth weight infants Cochrane Dababase Syst Rev. 2017. vol.16.p.187.
Ozsoylu S. Iron deficiency anemia in late preterm infants. Turk J.Pediatr. 2014. Vol.56.№1.p.119.
Korzeniewski S.J., Allred E., Logan J.W. et al. Elevated Endogenous Erythropoietin Concentrations Are Associated with Increased Risk of Brain Damage in Extremely Preterm Neonates. Plos One. 2015. vol.10.№3.p.83-115.
Holm M., Skranes J., Damman O. et al. Systemic endogenous erythropoietin and associated disorders in extremely preterm newborns. Arch Dis Child Fetal Neonatal Ed. 2016. vol. 101. №5. p.458-463.
Bechensteen A.G., Halvorsen S., Haga P. et al. Erythropoietin protein and iron supple-mentation and the prevention of anemia of prematurity. Acta Pediatr. 1996. vol.60.№4.p.930-935.
Ochiai M., Kurata H., Jnoul H.et al. An Elevation of Serum Ferritin Level Might Increase Clinical Risk for the Persistence of Patent Ductus Arteriosus, Sepsis and Bronchopulmonary Dysplasia in Erythropoietin – Treated. Very-Low –Birth. Weight Infants. Neonatology 2017. vol.111.№1.p.68-75.
AL-Ghananim R.T., Nalbant D., Schmidt R.L. et al. Reticulocyte Hemoglobin Content During the First Month of life in Critically/// Very Low Birth Weight Neonates Differs From Term Infants. Children and Adults J.Clin. Lab. Anal.2016. vol.30.№4.p.326-334.
Lorenz L., Peter A., Arand J. et al. Reference Ranges of Reticulocyte Hemoglobin Content in Preterm and Term Infants: A Retrospective Analysis. Neonatology, 2017. vol.111.№3.p.189-194.